A Study to Evaluate Sequential Administration of Injections of AGN-151586 Followed by BOTOX in Adult Participants for Treatment of Glabellar Lines
NCT07756580
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
120
Enrollment
INDUSTRY
Sponsor class
Conditions
Glabellar Lines
Interventions
DRUG:
AGN-151586
DRUG:
BOTOX
Sponsor
AbbVie